The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
| Summaries of Product Characteristics 31 - 60 of 137 |
|
|
|
Package
leaflet | Status for
supply | Name of the medicinal product |
|
|
|
European Medicines Agency's website:
Zeposia - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Zeqmelit 4 mg, 6 mg, 8 mg kalvo, suussa hajoava SPC 2023-11-08
|
|
|
|
European Medicines Agency's website:
Zerbaxa - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Zercepac - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Zessly - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Zevalin - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Zevtera 500 mg kuiva-aine välikonsentraatiksi infuusionestettä varten, liuos SPC 2022-11-21
|
|
|
|
European Medicines Agency's website:
Ziagen - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Ziaxel 180 mg/2 mg kapseli SPC 2004-05-19
|
|
PL
|
Resepti
|
Zidoval 7,5 mg-g emätingeeli SPC 2024-01-22
|
|
|
|
European Medicines Agency's website:
Ziextenzo - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Zilbrysq - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Zimbus Breezhaler - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Zinforo - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Zinplava - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Ziprasidon Krka 20 mg, 40 mg, 60 mg, 80 mg kapseli, kova SPC 2024-06-03
|
|
PL
|
Resepti
|
Ziprasidon Viatris 20 mg, 40 mg, 60 mg, 80 mg kapseli, kova SPC 2022-11-29
|
|
PL
|
Itsehoito
|
Zipzoc voidesukka SPC 2021-10-20
|
|
|
|
European Medicines Agency's website:
Zirabev - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Zithromax 250 mg tabletti, kalvopäällysteinen SPC 2023-06-09
|
|
PL
|
Resepti
|
Zithromax 40 mg-ml jauhe oraalisuspensiota varten SPC 2023-06-09
|
|
PL
|
Resepti
|
Zithromax 500 mg tabletti, kalvopäällysteinen SPC 2023-06-09
|
|
PL
|
Resepti
|
Zithromax IV 500 mg infuusiokuiva-aine, liuosta varten SPC 2023-06-09
|
|
PL
|
Resepti
|
Zocor 10 mg, 20 mg, 40 mg, 80 mg tabletti, kalvopäällysteinen SPC 2023-03-02
|
|
|
|
European Medicines Agency's website:
Zoely - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Zofran 2 mg-ml injektioneste, liuos SPC 2023-02-03
|
|
PL
|
Resepti
|
Zofran 4 mg, 8 mg tabletti, kalvopäällysteinen SPC 2023-02-03
|
|
PL
|
Resepti
|
Zofran Zydis 4 mg, 8 mg tabletti, kylmäkuivattu SPC 2023-02-03
|
|
|
|
European Medicines Agency's website:
Zokinvy - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Zoladex 10.8 mg implantaatti SPC 2023-04-21
|
|
|
